Angioedema Control Test 4 Weeks recall period (AECT4)
Angioedema Control Test 4 Weeks recall period (AECT4)
Couldn't load pickup availability
Description
The Angioedema Control Test (AECT) is a validated, easy to use questionnaire to determine disease control in patients with recurrent angioedema. It can be used in patients with histamine-mediated, bradykinin-mediated and idiopathic recurrent angioedema. The AECT is designed as a retrospective instrument and may be applied and evaluated quickly and easily during patient consultations.
The AECT was developed by a Charité team of scientists led by Dr. Karsten Weller and Dr. Marcus Maurer. Briefly, after a set of potential AECT items was developed, item evaluation and reduction were performed, for example, by means of impact analysis and by checking for face validity. In addition, the items of the final AECT were tested for their validity and reliability during a validation study.
Quick Facts AECT:
Number of items: 4
Suited for: Adults (≥18 years old) with histamine-mediated, bradykinin-mediated and idiopathic recurrent angioedema.
Assessment: retrospectively (recall period: 4 weeks)
Scoring: easy sum scoring, scoring template available
Cutoff-value: 10 points (<10 points indicate poorly controlled recurrent angioedema)
Copyright: Moxie GmbH (www.moxie-gmbh.de)
Terms of use: Free for routine clinical use and non-commercial research, fee for use in clinical trials/commercial research
References:
Weller K, Donoso T, Magerl M, Aygören-Pürsün E, Staubach P, Martinez-Saguer I, Hawro T, Altrichter S, Krause K, Siebenhaar F, Metz M, Zuberbier T, Freier D, Maurer M. Validation of the Angioedema Control Test (AECT) - A Patient-Reported Outcome Instrument for Assessing Angioedema Control. J Allergy Clin Immunol Pract. 2020, doi: 10,1016/y.jaip.2020.02.038.
Weller K, Donoso T, Magerl M, Aygören-Pürsün E, Staubach P, Martinez-Saguer I, Hawro T, Altrichter S, Krause K, Siebenhaar F, Metz M, Zuberbier T, Freier D, Maurer M. Development of the Angioedema Control Test - A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema. Allergy. 2019, doi: 10.1111/all.14144.
Commercial or non-commercial
If you are interested or on request, we will be happy to send you our PROMs (Patient Reported Outcomes Measures) on the various topics by e-mail.
Please understand that we have to charge a fee of 15 Euro per PRO when using our PROMs for commercial purposes. Commercial use include, for example, use in industry-sponsored studies, market research and similar purposes.
By non-commercial use we mean e.g. use for consultation hours in hospitals and private practices, use within scientific studies without sponsoring. The prerequisite is that no commercial interest is pursued.
Frequently Asked Questions
Why are there PRO (Patient Reported Outcomes) products that cost nothing and others that cost 15 Euros?
If you plan to use PRO (Patient Reported Outcomes) products (e.g. AAS, AE-QoL, UCT) commercially, there is a small fee per patient (15 €). This applies, for example, to industry-sponsored trials and clinical studies or market research.
You can order free versions, if you plan to use them for non commercial purposes, e.g. for patient management or for academia-driven non commercial
research projects. When you order PRO (Patient Reported Outcomes) products, these instruments are sent per e-mail.
I would like to use PRO (Patient Reported Outcomes) products commercially. Do I have to buy one version each for every time I plan to use it, even in the same patient?
No. Each PRO (Patient Reported Outcomes) products you purchase can be used multiple time by the same patient.
What do I do if PRO (Patient Reported Outcomes) products are not available for my country or in the language I need?
The version you are looking for is probably already under development. Feel free to get in touch with us by e-mail to check when it will be available.